James Sapirstein - Chairman and CEO, Director at Entero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and CEO, Director
Stock Symbol
ENTO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

James Sapirstein - trading volume in the past year for Entero Therapeutics, Inc.

Holdings reported by James Sapirstein for Entero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35.8K $38.3K $1.07 Jul 2, 2024 Direct

Transactions reported by James Sapirstein for Entero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.